Lengo Therapeutics, Inc.
Pharmaceutical company · Menlo Park, California, United States
Lengo Therapeutics, Inc. is a pharmaceutical company headquartered in Menlo Park, California, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2021.
Lengo Therapeutics at a glance
What does Lengo Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $17.7 million sold (2021).
Frequently asked questions about Lengo Therapeutics
Where is Lengo Therapeutics headquartered?
Lengo Therapeutics, Inc. is headquartered in Menlo Park, California, United States.
What does Lengo Therapeutics do?
Lengo Therapeutics, Inc. is a pharmaceutical company.
When was Lengo Therapeutics founded?
The earliest incorporation on record for Lengo Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- AN2 Therapeutics, Inc.Menlo Park, California, United States
- Oruka Therapeutics, Inc.Menlo Park, California, United States
- Dermira, Inc.Menlo Park, California, United States
- Orca BioSystems IncMenlo Park, California, United States
- CohBar, Inc.Menlo Park, California, United States
- Radionetics Oncology, Inc.Menlo Park, California, United States
- Forty Seven, Inc.Menlo Park, California, United States
- Attenua, Inc.Menlo Park, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences